【レポートの概要(一部)】
1. Report Overview
1.1 The Global Pharma Wholesale and Distribution Industry and Market Review
1.2 The Global Pharma Wholesale and Distribution Industry Structure
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Report
1.6 Who is This Study For?
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Pharma Wholesale and Distribution
2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
2.1.1 Full-Line Wholesalers (FLWs)
2.1.2 Short-Line Wholesalers (SLWs)
2.2 The Chain of Distribution: Wholesalers vs. Logistics Service Providers
2.2.1 Secondary Wholesalers
2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
2.2.3 Major Wholesalers: Distribute a Large Amount of Products to Generate High Profit
2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
2.2.5 Pharmacy Benefit Managers
2.3 Generating Revenue and Profit
2.3.1 Forward Buying to Avoid Price Increases
2.3.2 Fee-for-Service: A Clearer Pricing Structure
2.3.2.1 Inventory Management Agreements
2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
2.3.4 Reimbursement and Wholesalers
2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
2.3.6 Parallel Trade: Different Attitudes in Europe and the US
3. The World Pharmaceutical Wholesale and Distribution Market, 2014-2024
3.1 The World Pharmaceutical Wholesale and Distribution Market in 2013, Restricted by Government Price Reductions and Generic Substitution
3.2 The Pharmaceutical Wholesale and Distribution: World Market Forecast, 2014-2024
3.3 Branded and Generic Drugs: Revenue vs. Profit, 2014-2024
3.3.1 Branded and Generic Drugs: Revenue Generation, 2013
3.3.2 Branded Drugs, Generic Drugs and Others: Revenue Forecasts, 2014-2024
3.3.3 Branded Drugs: Revenue Forecast, 2014-2024
3.3.4 Generic Drugs: Revenue Forecast, 2014-2024
4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2014-2024
4.1 Leading National Markets: The US Dominated in 2013
4.2 Leading National Markets: Revenue The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
4.3 The US Pharma Wholesale and Distribution Market
4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
4.3.3 An Increase in Fee-For-Service Activity
4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2014-2024
4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
4.4.1 Differences Between the US and Europe
4.4.2 State-Funded Healthcare and Reimbursement
4.4.3 EU5: Market Forecast, 2014-2024
4.4.4 Germany: Pharma Wholesale and Distribution Market, 2013
4.4.4.1 Healthcare Reform
4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.5 France: Pharma Wholesale and Distribution Market, 2013
4.4.5.1 France: Social Security Finance Bill 2014
4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.6 Italy: Pharma Wholesale and Distribution Market, 2013
4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.7 Spain: Pharma Wholesale and Distribution Market, 2013
4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.8 UK: Pharma Wholesale and Distribution Market, 2013
4.4.8.1 Price Cuts in the UK
4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.5 Japan: Pharma Wholesale and Distribution Market, 2013
4.5.1 Drug Pricing and Performing Fees in Japan
4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.6 China: Pharma Wholesale and Distribution Market, 2013
4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2013
4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.7 Brazil: Pharma Wholesale and Distribution Market, 2013
4.7.1 Drug Price Controls in Brazil
4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2013
4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.8 India: Pharma Wholesale and Distribution Market, 2013
4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.9 Russia: Pharma Wholesale and Distribution Market, 2013
4.9.1 Drug Pricing Controls in Russia
4.9.2 Market Trends in Russia
4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.10 Conclusion
5. Leading Pharma Wholesalers and Distributors in 2014: Current and Future Performance
5.1 The Leading Wholesale and Distribution Companies in 2013
5.2 Revenue vs. Profit
5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2014-2024
5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
5.4.1 McKesson: Historical Performance, 2008-2013
5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
5.4.3 McKesson: Revenue Forecast, 2014-2024
5.5 Cardinal Health: The World’s Second Largest Pharma Wholesaler
5.5.1 Cardinal Health: Historical Performance, 2008-2013
5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
5.5.3 Cardinal Health: Revenue Forecast, 2014-2024
5.6 AmerisourceBergen: Third Largest Global Pharma Wholesaler and Distributor
5.6.1 AmerisourceBergen: Historical Performance, 2008-2013
5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
5.6.3 AmerisourceBergen: Revenue Forecast 2014-2024
5.7 Alliance Boots: The Largest European Wholesaler
5.7.1 Alliance Boots: Historical Performance, 2008-2013
5.7.2 Future Strategies of Alliance Boots: Merger Plan with Walgreens to Become the Largest Provider of Healthcare Services
5.7.3 Alliance Boots: Revenue Forecast, 2014-2024
5.8 MEDIPAL HOLDINGS CORPORATION: Japan’s Leading Pharmaceutical Wholesaler
5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2008-2013
5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2014-2024
5.9 The PHOENIX Group: Second Biggest Wholesaler in Europe
5.9.1 The PHOENIX Group: Historical Performance, 2008-2013
5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisitions
5.9.3 The PHOENIX Group: Revenue Forecast, 2014-2024
5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
5.10.1 SINOPHARM: Historical Performance, 2008-2013
5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
5.10.3 SINOPHARM: Revenue Forecast, 2014-2024
5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
5.11.1 Alfresa Holdings: Historical Performance, 2008-2013
5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
5.11.3 Alfresa Holdings: Revenue Forecast, 2014-2024
5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
5.12.1 SUZUKEN CO., LTD: Historical Performance, 2008-2013
5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2014-2024
5.13 Shanghai Pharmaceuticals Holding: China’s Second Largest Wholesaler
5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2008-2013
5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
5.13.3 Shanghai Pharma: Revenue Forecast, 2014-2024
6. Qualitative Analysis of the Pharma Wholesale and Distribution Market
6.1 Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2014
6.1.1 The Insatiable Demand for Drugs: A Recession-Proof Industry?
6.1.2 Wholesalers Do More than Deliver Drugs
6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
6.1.3 Large Companies Dominate the Market
6.1.4 Despite High Revenues, Profit Margins Are Low
6.1.5 Government-Induced Drug Price Pressures Restrict Profits
6.1.6 The Problem of Counterfeit Drugs
6.2. The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2014-2024
6.2.1The Demand for Pharmaceuticals is Increasing
6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
6.2.4 The Promotion of Drug Therapy in the US
6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
6.2.6 Increased Adoption of the DTP Distribution Model
6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
6.2.6.2 DTP in the UK Since 1991
6.2.6.3 DTP in Poland: The Second European Country to Adopt the DTP Model
6.2.6.4 Further Expansion of the DTP Model
6.2.7 The Threat of Healthcare Budget Cuts
6.2.7.1 Healthcare Budget Cuts in Germany
6.2.7.2 Healthcare Budget Cuts in France
6.2.7.3 Healthcare Budget Cuts in Italy
6.2.7.4 Healthcare Budget Cuts in Spain
6.2.7.5 Healthcare Budget Cuts in the UK
6.2.8 Do Large Pharmacy Chains Pose a Threat?
6.2.8.1 Case Study: Walmart and the $4.0 Prescription Scheme
6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
6.2.9 Does the Diversion and Re-importation of Medicines Pose a Threat to the Industry?
6.2.10 The Threat of Industry Consolidation
6.3 Social, Technological, Economical and Political Factors Influencing the Market, 2014-2024 (STEP Analysis)
6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
6.3.2 Political Factor: Combating Counterfeit Medicines
6.3.2.1 The US and E-Pedigree: Becoming Law in California
6.3.2.2 European Pedigree Legislation
6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
6.2.3.4 Serialisation for Wholesalers: Opportunity or a Challenge?
7. Research Interviews
7.1 Interview with Mr Chris Frost, Sales Director of AAH Pharmaceuticals Ltd. (Celesio UK), Coventry
7.1.1 Current Status and Evolution of Pharma Wholesale and Distribution Market in the UK
7.1.2 Driving Factors of the Pharma Wholesale and Distribution Market in the UK
7.1.3 Future of the UK Pharma Wholesale and Distribution Market
7.1.4 Celesio UK Accounted for More Than 60% of the Group’s Total Retail Pharmacy Business in 2013
7.1.5 The Outcome of McKesson’s Acquisition of Celesio AG
7.1.6 Prominent Business Segments of Celesio AG in the Future
7.2 Interview with Dr Evelyn Walter, Co-Founder and Director of the Institute for Pharmaeconomic Research (IPF), Vienna
7.2.1 On Direct-to-Pharmacy Distribution
7.2.2 On the Effect of Drug Pricing Pressures on the Supply of Pharmaceuticals
7.2.3 On the Role of Pharmaceutical Wholesalers and Distributors in European Healthcare Systems
7.2.4 On the Impact of Counterfeit Drugs
7.2.5 On the Efficacy of the Pharmaceutical Wholesale and Distribution Industry
8. Conclusions from the Research and Analysis
8.1 The Future of the Pharma Wholesale and Distribution Market
8.2 The Leading National Pharma Wholesale and Distribution Markets
8.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
8.4 Trends in the Pharma Wholesale and Distribution Industry
8.4.1 Generics Will Threaten Revenue
8.4.2 Manufacturers Will Deliver More Drugs Directly
8.4.3 There Will Be Greater Demand for Specialty Medicines
8.4.4 Consolidation Will Drive Growth
8.4.5 Anti-Counterfeiting Demands Will Add to Wholesaler’s Costs
【レポート販売概要】
■ タイトル:世界の医薬品卸売及び流通市場:地域別分析、主要企業分析■ 英文:PHARMA WHOLESALE AND DISTRIBUTION INDUSTRY AND MARKET: WORLD OUTLOOKS AND FORECASTS 2014-2024
■ 発行日:2014年9月
■ 調査会社:visiongain
■ 商品コード:VISG409042
■ 調査対象地域:グローバル
- Burns:グローバル臨床試験レビューH1, 2013Burns Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Burns Global Clinical Trials Review, H1, 2013" provides data on the Burns clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Burns. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across …
- 坐骨神経痛治療の世界市場2019-2023About this market Sciatica is often confused with general back pain. Sciatica can cause long-term pain in the lower back if the condition is left untreated. Hence, various government and non-governmental organizations are initiating certain programs to increase awareness among people about the condition and avoid delay in diagnosis. For instance, Ortholnfo, the patient education site of the Americ …
- カメラモジュールの世界市場:イメージセンサー(CMOS、CCD)、レンズモジュールIn the modern dynamic world of technology, the camera modules are widely used in a range of applications such as consumer electronics, healthcare, industrial, security & surveillance, automotive, and aerospace & defense. The consumer electronics market has impacted the camera modules market mostly owing to the usage of CCD and CMOS sensors-enabled camera modules. The demand for digital camera has …
- 世界の触媒(Catalyst)市場動向(2012-2016)TechNavio's analysts forecast the Global Catalyst market to grow at a CAGR of 4.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for clean fuels. Vendors of the Global Catalyst market are also increasing focused on introducing innovative products and advanced technology into the market. However, the fluctuating raw material pri …
- 次世代シーケンシングの世界市場分析:用途別(HLA検査、出生前検査、腫瘍学、特発性および感染症)、技術別(全ゲノム配列、全エクソーム配列、標的配列決定および再配列)、ワークフロー別(NGSプレシーケンシング、NGSシーケンシング、NGSデータ解析)、セグメント予測The global market for next generation sequencing is expected to reach USD 27.87 billion by 2022. Technological developments in the field of genomic sequencing is expected to cause a decline in the cost of sequencing per base pair and thereby, greatly enhance adoption and usage rates of next generation sequencing over the forecast period. With this expected increase in usage of whole genome sequenc …
- IoTセンサーの世界市場予測(~2023年):圧力、温度、湿度、磁力計、ジャイロスコープ、加速度計、画像、慣性“IoT sensors market to grow at 33.60% CAGR during forecast period”The IoT sensors market is expected to be valued at USD 5.28 by 2018 and is projected to reach USD 22.48 billion by 2023, at a CAGR of 33.60% between 2018 and 2023. The growth of the IoT sensors market can be attributed to the increased use of sensors in IoT devices and other applications owing to their reduction in size, plummeting …
- 流量計の世界市場:アナログ流量計、スマート流量計About the Flow Meter Market Flow meters measure the mass, quantity, pressure and velocity of any fluid or gas flowing through a pipeline. These meters are classified into two types: • Analog flow meters • Smart/intelligent flow meters At present, the majority of the flow meters used are traditional analog flow meters, which are used to measure the flow of the fluid (oil and water) and gas (LPG, NG …
- 家族性高コレステロール血症(II型高リポ蛋白血症)(Familial Hypercholesterolemia):治療薬開発パイプライン動向(2015年上半期版)Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015’, provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic developme …
- フレキシブル電池の世界市場:薄膜リチウムイオン電池、フレキシブルリチウムポリマー電池、印刷電池、カーブドバッテリー、ペーパー電池Flexible batteries are the upcoming trend in the battery industry. The flexible batteries are flexible, light weight, and easy to integrate into products with limited internal space. These batteries have the ability to be folded, twisted, cut into halves without any loss of efficiency. Many institutes and companies are investing majorly to test and develop the potential of the flexible battery and …
- BRIC(ブラジル/ロシア/インド/中国)の内視鏡洗浄装置市場動向(~2020)BRIC Endoscopic Reprocessors Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Endoscopic Reprocessors Market Outlook to 2020", provides key market data on the BRIC Endoscopic Reprocessors market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - High-End Endoscopic Reprocessors, Mid-Range Endoscopic Repr …
- カメラ用付属品の世界市場:カメラレンズ、カメラバック、カメラケース、カメラ支持具、フラッシュガンAbout Camera Accessories A few major camera accessories include lenses, flashguns, bags, cases, straps, supports, and memory cards. Users primarily invest in camera accessories to protect cameras from any physical damage and for improved functionality. Technavio’s analysts forecast the global camera accessories market to grow at a CAGR of 3.35% during the period 2016-2020. [Covered in this report] …
- 試験室用分析機器の世界市場2017-2021About laboratory analytical instrumentsLaboratory analytical instruments are used in research processes to measure, analyze, and verify the unproven quantities, properties, and phenomena of an element or material. Compared with other instruments such as scales and chronometers, these are more specialized and sophisticated in terms of their use. Technavio’s analysts forecast the global laboratory a …
- 勃起リングの世界市場2016-2020About Erection RingA cock ring or erection ring is worn to prolong and heighten orgasms, leading to a satisfactory sexual intercourse. Generally, the mechanism of erection rings is that they trap the blood flow in the penis and stops the blood going backward. Therefore, the use of erection rings will help men experience increased sensitivity along with harder erections. Another advantage of using …
- 特殊スピリッツ(蒸留酒)の世界市場2016-2020About Specialty Spirits Specialty spirits are region-specific traditional spirits. Baijiu in China, soju in South Korea, sochu in Japan, Cachaça in Brazil, and raki in Turkey are some of the popular specialty spirits. The global specialty spirits market is dominated by APAC. China is the largest market for specialty spirits. Rising disposable incomes, especially in developing nations, coupled with …
- 乗り物酔い用薬の世界市場:抗コリン薬、抗ヒスタミン薬Global Motion Sickness Drugs Market: About this market Motion sickness drugs are pharmaceutical agents that are used to treat nausea and vomiting caused due to motion sickness. Technavio’s motion sickness drugs market analysis considers sales from both anticholinergics and antihistamines. Our analysis also considers the sales of motion sickness drugs in Asia, Europe, North America, and ROW. In 201 …